AAAAAA
Results: 1-25/32
Authors:
WAHLBECK K
RIMON R
Citation: K. Wahlbeck et R. Rimon, CSF ACE CORRELATES WITH DURATION OF ILLNESS IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 103-103
Authors:
PURAS A
SCHERKSNIENE R
VENALAINEN E
RIMON R
Citation: A. Puras et al., A PROSPECTIVE-STUDY OF CLOZAPINE MONOTHERAPY IN TREATMENT-RESISTANT SCHIZOPHRENIC-PATIENTS IN LITHUANIA, Nordic journal of psychiatry, 52, 1998, pp. 1-1
Authors:
JOFFE G
RYBAK J
BURKIN M
BURKIN D
APPELBERG B
JOFFE M
GADEKE R
RIMON R
Citation: G. Joffe et al., CLOZAPINE RESPONSE IN EARLY TREATMENT-RESISTANT SCHIZOPHRENIA, Nordic journal of psychiatry, 52, 1998, pp. 16-16
Authors:
JOFFE G
RIMON R
Citation: G. Joffe et R. Rimon, ADJUNCTIVE NEFAZODONE IN NEUROLEPTIC-TREATED SCHIZOPHRENIC-PATIENTS WITH DEPRESSIVE AND NEGATIVE SYMPTOMS - A PRELIMINARY-REPORT, Nordic journal of psychiatry, 52, 1998, pp. 26-26
Authors:
RIMON R
NOUSIAINEN U
LEPOLA U
KINNUNEN J
TIIHONEN P
MERVAALA E
Citation: R. Rimon et al., SPECTRAL ELECTROENCEPHALOGRAM AND CLINICAL FOLLOW-UP DURING ALPRAZOLAM AND IMIPRAMINE TREATMENT IN PANIC DISORDER, Nordic journal of psychiatry, 52(3), 1998, pp. 245-249
Authors:
AHONEN J
CHEINE M
RIMON R
Citation: J. Ahonen et al., BETA-BLOCKING-AGENTS AS ADD-ON DRUGS IN SCHIZOPHRENIA - A SYSTEMATIC COCHRANE REVIEW, Nordic journal of psychiatry, 52(2), 1998, pp. 108-108
Authors:
WAHLBECK K
AHOKAS A
MIETTINEN K
NIKKILA H
RIMON R
Citation: K. Wahlbeck et al., HIGHER CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME LEVELS IN NEUROLEPTIC-TREATED THAN IN DRUG-FREE PATIENTS WITH SCHIZOPHRENIA, Schizophrenia bulletin, 24(3), 1998, pp. 391-397
Authors:
KATILA H
APPELBERG B
RIMON R
Citation: H. Katila et al., NO DIFFERENCES IN PHOSPHOLIPASE-A(2) ACTIVITY BETWEEN ACUTE PSYCHIATRIC-PATIENTS AND CONTROLS, Schizophrenia research, 26(2-3), 1997, pp. 103-105
Authors:
JOFFE G
RYBAK J
BURKIN M
BURKIN D
APPELBERG B
JOFFE M
GADEKE R
RIMON R
Citation: G. Joffe et al., CLOZAPINE RESPONSE IN EARLY TREATMENT-RESISTANT SCHIZOPHRENIA, Nordic journal of psychiatry, 51(2), 1997, pp. 99-99
Authors:
WAHLBECK K
AHOKAS A
NIKKILA H
MIETTINEN K
RIMON R
Citation: K. Wahlbeck et al., A LONGITUDINAL-STUDY OF CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME IN NEUROLEPTIC-TREATED SCHIZOPHRENIA, Progress in neuro-psychopharmacology & biological psychiatry, 21(4), 1997, pp. 591-599
Authors:
APPELBERG B
KATILA H
RIMON R
Citation: B. Appelberg et al., PLASMA INTERLEUKIN-1-BETA AND SLEEP ARCHITECTURE IN SCHIZOPHRENIA ANDOTHER NONAFFECTIVE PSYCHOSES, Psychosomatic medicine, 59(5), 1997, pp. 529-532
Authors:
LEINONEN E
LEPOLA U
KOPONEN H
MEHTONEN OP
RIMON R
Citation: E. Leinonen et al., LONG-TERM EFFICACY AND SAFETY OF MILNACIPRAN COMPARED TO CLOMIPRAMINEIN PATIENTS WITH MAJOR DEPRESSION, Acta psychiatrica Scandinavica, 96(6), 1997, pp. 497-504
Authors:
JOFFE G
VENALAINEN E
TUPALA J
HILTUNEN O
WAHLBECK K
GADEKE R
RIMON R
Citation: G. Joffe et al., THE EFFECT OF CLOZAPINE ON THE COURSE OF ILLNESS IN CHRONIC-SCHIZOPHRENIA - FOCUS ON TREATMENT OUTCOME IN OPEN-CARE PATIENTS, Schizophrenia research, 18(2-3), 1996, pp. 5-5
Authors:
WAHLBECK K
AHOKAS A
NIKKILA H
RIMON R
Citation: K. Wahlbeck et al., HIGHER CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME LEVELS IN NEUROLEPTIC-TREATED THAN IN DRUG-FREE SCHIZOPHRENICS, Schizophrenia research, 18(2-3), 1996, pp. 14-14
Authors:
KATILA H
APPELBERG B
RIMON R
Citation: H. Katila et al., PHOSPHOLIPASE-A(2) ACTIVITY IN PSYCHOTIC-PATIENTS, Schizophrenia research, 18(2-3), 1996, p.
Authors:
APPELBERG B
KATILA H
RIMON R
Citation: B. Appelberg et al., PLASMA INTERLEUKIN-1-BETA AND SLEEP ARCHITECTURE IN SCHIZOPHRENIA ANDOTHER NONAFFECTIVE PSYCHOSES, Schizophrenia research, 18(2-3), 1996, p.
Authors:
WAHLBECK K
AHOKAS A
NIKKILA H
RIMON R
Citation: K. Wahlbeck et al., HIGHER CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME LEVELS IN NEUROLEPTIC-TREATED THAN IN DRUG-FREE SCHIZOPHRENICS, Nordic journal of psychiatry, 50(2), 1996, pp. 98-98
Authors:
JOFFE G
VENALAINEN E
TUPALA J
HILTUNEN O
WAHLBECK K
GADEKE R
RIMON R
Citation: G. Joffe et al., THE EFFECT OF CLOZAPINE ON THE COURSE OF ILLNESS IN CHRONIC-SCHIZOPHRENIA - FOCUS ON TREATMENT OUTCOME IN OUT-PATIENTS, International clinical psychopharmacology, 11(4), 1996, pp. 265-272
Authors:
WAHLBECK K
SUNDBLOM M
KALSO E
TIGERSTEDT I
RIMON R
Citation: K. Wahlbeck et al., ELEVATED PLASMA VASOPRESSIN AND NORMAL CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME IN CHRONIC PAIN DISORDER, Biological psychiatry, 40(10), 1996, pp. 994-999
Authors:
LAHDELMA RL
KATILA H
HIRATAHIBI M
ANDERSSON L
APPELBERG B
RIMON R
Citation: Rl. Lahdelma et al., ATYPICAL LYMPHOCYTES IN SCHIZOPHRENIA, European psychiatry, 10(2), 1995, pp. 92-96
Authors:
NIKKILA H
MULLER K
AHOKAS A
MIETTINEN K
ANDERSSON LC
RIMON R
Citation: H. Nikkila et al., ABNORMAL-DISTRIBUTIONS OF T-LYMPHOCYTE SUBSETS IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ACUTE SCHIZOPHRENIA, Schizophrenia research, 14(3), 1995, pp. 215-221
Authors:
RIMON R
LEPOLA U
JOLKKONEN J
HALONEN T
RIEKKINEN P
Citation: R. Rimon et al., CEREBROSPINAL-FLUID GAMMA-AMINOBUTYRIC-ACID IN PATIENTS WITH PANIC DISORDER, Biological psychiatry, 38(11), 1995, pp. 737-741
Authors:
KATILA H
APPELBERG B
HURME M
RIMON R
Citation: H. Katila et al., PLASMA-LEVELS OF INTERLEUKIN-1-BETA AND INTERLEUKIN-6 IN SCHIZOPHRENIA, OTHER PSYCHOSES, AND AFFECTIVE-DISORDERS, Schizophrenia research, 12(1), 1994, pp. 29-34
Authors:
RIMON R
KUOPPASALMI K
NAUKKARINEN H
LANG S
SANDQVIST A
LEINONEN E
Citation: R. Rimon et al., CLOZAPINE DECREASES THE LEVEL OF ANXIETY AND AGGRESSIVE-BEHAVIOR IN PATIENTS WITH THERAPY-REFRACTORY SCHIZOPHRENIA, Nordic journal of psychiatry, 48(5), 1994, pp. 315-320
Authors:
KATILA H
HURME M
WAHLBECK K
APPELBERG B
RIMON R
Citation: H. Katila et al., PLASMA AND CEREBROSPINAL-FLUID INTERLEUKIN-1-BETA INTERLEUKIN-6 IN HOSPITALIZED SCHIZOPHRENIC-PATIENTS, Neuropsychobiology, 30(1), 1994, pp. 20-23